Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy

Metabolic Brain Disease

Volumn 15, Issue 3, 2000, Pages 173-178

  Weissenborn, K ^a   Berding, G ^a   Kostler H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

D2 dopamine receptor; Dopamine transporter; Hepatic encephalopathy

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; IODINE 123; IODOBENZAMIDE I 123; UNCLASSIFIED DRUG;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DOPAMINE METABOLISM; DOPAMINE UPTAKE; HEPATIC ENCEPHALOPATHY; HUMAN; IMAGE ANALYSIS; LIVER CIRRHOSIS; MALE; NEUROPATHOLOGY; RECEPTOR BINDING; RECEPTOR DENSITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOMATOLOGY;

AGED; BENZAMIDES; BIOLOGICAL TRANSPORT; CASE-CONTROL STUDIES; CONTRAST MEDIA; DOPAMINE; DOPAMINE ANTAGONISTS; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROTEIN BINDING; PYRROLIDINES; RECEPTORS, DOPAMINE D2; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034496202     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011107607993     Document Type: Article

References (13)

1. Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy
2. Portal-systemic encephalopathy: A disorder of neuron-astrocytic metabolic trafficking
3. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double-blind controlled trial
4. Loss of dopamine-D2 receptor binding sites in parkinsonian plus syndromes
5. Does ammonia contribute to increased GABA-ergic neurotransmission in liver failure?
6. Recent biochemical studies of the dopamine transporter - A CNS drug target
7. An image of the brain in liver disease
8. Selective loss of pallidal dopamine D2 receptor density in hepatic encephalopathy
9. Cognitive impairments associated with Parkinson's disease and other movement disorders
10. B in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy
11. Multiple system atrophy: Natural history, MR1 morphology, and dopamine receptor imaging with 123IBZM-SPECT
12. The basal ganglia and portosystemic encephalopathy
13. The PSE-Test: An attempt to standardize neuropsychological assessment of latent portosystemic encephalopathy (PSE)